Lucy Letby: Why new evidence is challenging the verdict

The case against Lucy Letby has re-entered the news cycle because fourteen neonatologists and paediatricians say the medical record shows no murders at all. Their February 2025 review, delivered at a London press conference, concludes that every death and collapse at Countess of Chester Hospital resulted from natural causes or substandard care. The finding lands while Letby’s legal team waits for the Criminal Cases Review Commission to decide whether the original verdicts should return to the Court of Appeal.

Expert panel findings

The panel, chaired by Canadian neonatologist Dr Shoo Lee, examined the same clinical notes the jury saw. They found no radiographic or laboratory proof that air had been injected into any infant’s circulation. They also rejected the prosecution’s reading of a 1989 paper on air embolism that Lee himself co-authored, noting the symptoms described in court do not match the cases under review.

Panel members reviewed every blood-gas result, X-ray, and nursing entry. They concluded that collapses followed documented problems with ventilation, infection control, or staffing shortages. No deliberate act was required to explain the pattern of events.

The group produced thirty-one separate reports totalling thousands of pages. Those documents now form the core of the new application sitting with the CCRC.

Air embolism claims examined

At trial the prosecution argued that unusual skin mottling proved air had been forced into veins. The panel found the same mottling occurs during routine resuscitation when circulation is compromised. No autopsy photographs or microscopic slides supported the air-injection theory.

Lee told reporters the original testimony conflated a diagnostic sign with proof of intent. The panel saw no contemporaneous notes recording the sudden appearance of the rash described in court.

Without that sign, the prosecution’s central mechanism for seven murder counts loses its medical anchor.

Insulin evidence reviewed

A separate seven-expert dossier released in April 2025 questioned the reliability of the insulin tests used to allege poisoning. The assays were performed on blood taken after the babies had received intravenous fluids that can distort readings.

Experts noted the absence of C-peptide measurements that would distinguish injected insulin from the body’s own production. Without those values, the results cannot prove external administration.

The dossier argues the insulin findings should never have reached the jury in their current form.

Witness credibility issues

One prosecution expert, endocrinologist Peter Hindmarsh, faced a fitness-to-practise investigation by his former employer that was not disclosed to the defence before trial. Court records show the inquiry concerned clinical judgment in another setting.

Letby’s barrister Mark McDonald submitted the undisclosed material to the CCRC in early 2025. The commission must now weigh whether non-disclosure meets the threshold for a referral.

The revelation has prompted renewed scrutiny of how expert conflicts are handled in complex medical trials.

CCRC application status

The preliminary application arrived at the Criminal Cases Review Commission on the evening of 3 February 2025. Staff confirmed they have begun assessing whether the new material creates a real possibility that the Court of Appeal would quash the convictions.

Because the case involves seventeen infants and dozens of medical issues, the review is expected to take longer than average. The commission has not set a public timetable.

Any referral would trigger a full re-hearing, not an automatic release.

Political and media response

Conservative MP David Davis has twice called for an urgent re-examination, first in January 2025 and again in June. He cited the panel’s conclusions as grounds for pausing related inquiries until the CCRC finishes its work.

Two documentaries released in 2025 and 2026 have aired interviews with clinicians who now express doubt about the original narrative. One unnamed doctor told filmmakers of a lingering “tiny, tiny guilt” that the wrong person may have been convicted.

National outlets have framed the developments as the latest in a line of UK cases where medical evidence later faced re-evaluation.

Thirlwall Inquiry context

The public inquiry led by Lady Justice Thirlwall continues under the assumption that Letby committed the crimes. Its terms of reference focus on hospital governance rather than the safety of the convictions.

Letby’s representatives have asked the inquiry to pause witness hearings until the CCRC decides. The inquiry chair has so far declined, noting the panel’s findings remain untested in court.

The procedural split leaves two parallel processes running on different premises.

International comparisons

US audiences following the story often cite cases such as the 1990s nurse convictions later overturned on statistical or forensic grounds. The Lucy Letby panel review echoes those reversals by prioritising primary medical data over interpretive testimony.

Legal scholars note the CCRC’s “real possibility” test resembles the US “actual innocence” gateway in habeas proceedings. Both require fresh evidence that undermines confidence in the original verdict.

Whether the British system moves faster than American post-conviction litigation remains to be seen.

Next procedural steps

The CCRC will determine whether the thirty-one reports, the insulin critique, and the witness non-disclosure together meet the statutory test. If they do, the commission refers the case; if not, applicants may return with further material.

Letby remains in prison serving fifteen whole-life orders. Any successful referral would not automatically vacate those orders.

The outcome will test how the justice system weighs new expert consensus against a jury’s earlier findings.

Forward implications

If the CCRC refers the case, the Court of Appeal will confront a record built on contested medical interpretation rather than direct eyewitness proof. A successful appeal would require the Crown to decide whether to seek a retrial or accept that the evidence no longer supports the convictions. The process, whichever direction it takes, will shape future handling of complex neonatal prosecutions and the standards expected of expert testimony in UK courts.